PDCD1 and neoplasm: Moreover, a significant reduction of surface PD-L1 in tumor cells after Exo-PD-1 treatment was observed, which could be rescued by CME inhibitors but not CDE inhibitors (Fig. 4D), suggesting a possible clathrin-mediated downregulation of PD-L1 induced by Exo-PD-1.